Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Allied Market Research | PRODUCT CODE: 1179651

Cover Image

PUBLISHER: Allied Market Research | PRODUCT CODE: 1179651

Bacteriocins and Protective Cultures Market By Target Microorganism (Yeasts and Molds, Bacteria), By Application (Dairy and Dairy Products, Meat and Poultry Products, Seafood, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

PUBLISHED:
PAGES: 233 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Cloud Access (Single User License)
USD 3570
PDF (Business License)
USD 5730
PDF (Enterprise User License) & Excel (Data Pack) & Free Update
USD 9600

Add to Cart

The global bacteriocins and protective cultures market size was valued at $421.3 million in 2021 and is estimated to reach $768.5 million by 2031, registering a CAGR of 6.3% from 2022 to 2031.

Products intended to replace artificial preservatives and so encourage healthy eating are typically what distinguish the worldwide protective cultures market, notably in the food and beverage sector. Various bioscience firms that create all-natural solutions for food ingredients produce and market protective cultures for food and beverage goods. Numerous hypermarkets, department stores, and retail outlets have opened as a result of the expanding retail industry and the rise in FDI. It is crucial to avoid food products at these businesses from spoiling because they may have travelled great distances to get there. This factor creates lucrative opportunities in the global protective cultures markets over the forecast period.

As many of the chemical food additives used today may raise harmful concerns, modern society is more aware about the significance of food safety. For this reason, it is advantageous to highlight the advantages of natural resources and dietary benefits. Natural food without chemical additives are more popular due to their health benefits, thus growing demand for clean label and organic food products is expected to boost the demand for bacteriocins and protective culture during the forecast period.

According to the bacteriocins and protective cultures market analysis, the bacteriocins and protective cultures market is segmented into target organism, application and region. On the basis of target organism, the market is categorized into yeasts & molds and bacteria. By application, it is segmented into dairy and dairy products, meat and poultry products, seafood and others. On the basis of region, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of Asia-Pacific), and LAMEA (Brazil, Argentina, UAE, Turkey, South Africa and Rest of LAMEA).

Region wise, the Asia-Pacific region has significantly increased its market share for bacteriocins and protective cultures, and it is anticipated that it will maintain this share throughout the projected period. This is mostly attributable to rising milk product consumption and efforts to increase production capacity. Due to the consumption of dairy and organic goods, the region is expected to rise quickly over the forecast period and have the highest CAGR. Its population is also expected to grow, and awareness of cultural traditions, westernization, and shifting eating habits is also expected to increase.

The major players operating in the market are Aristomenis D. Phikas and Co SA., Biochem S.R.L,  CHR. HANSEN HOLDING A/S, Dalton Biotecnologie S.r.l, DSM, M Food Group GMBH, Proxis Developpement, Puratos Group NV, Sacco S.R.L and Soyuzsnab Group of Companies..

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the bacteriocins and protective cultures market analysis from 2021 to 2031 to identify the prevailing bacteriocins and protective cultures market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the bacteriocins and protective cultures market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global bacteriocins and protective cultures market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Target Microorganism

  • Yeasts and Molds
  • Bacteria

By Application

  • Dairy and Dairy Products
  • Meat and Poultry Products
  • Seafood
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Rest Of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest Of Asia-Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Turkey
    • South Africa
    • Rest Of LAMEA
  • Key Market Players
    • Aristomenis D. Phikas and Co SA.
    • Biochem S.R.L
    • CHR. HANSEN HOLDING A/S
    • Dalton Biotecnologie S.r.l
    • DSM
    • M Food Group GMBH
    • Proxis Developpement
    • Puratos Group NV
    • Sacco S.R.L
    • Soyuzsnab Group of Companies
Product Code: A16877

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY TARGET MICROORGANISM

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Yeasts and Molds
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Bacteria
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country

CHAPTER 5: BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY APPLICATION

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Dairy and Dairy Products
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Meat and Poultry Products
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Seafood
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country
  • 5.5 Others
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market analysis by country

CHAPTER 6: BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY REGION

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 North America
    • 6.2.1 Key trends and opportunities
    • 6.2.2 North America Market size and forecast, by Target Microorganism
    • 6.2.3 North America Market size and forecast, by Application
    • 6.2.4 North America Market size and forecast, by country
      • 6.2.4.1 U.S.
      • 6.2.4.1.1 Market size and forecast, by Target Microorganism
      • 6.2.4.1.2 Market size and forecast, by Application
      • 6.2.4.2 Canada
      • 6.2.4.2.1 Market size and forecast, by Target Microorganism
      • 6.2.4.2.2 Market size and forecast, by Application
      • 6.2.4.3 Mexico
      • 6.2.4.3.1 Market size and forecast, by Target Microorganism
      • 6.2.4.3.2 Market size and forecast, by Application
  • 6.3 Europe
    • 6.3.1 Key trends and opportunities
    • 6.3.2 Europe Market size and forecast, by Target Microorganism
    • 6.3.3 Europe Market size and forecast, by Application
    • 6.3.4 Europe Market size and forecast, by country
      • 6.3.4.1 Germany
      • 6.3.4.1.1 Market size and forecast, by Target Microorganism
      • 6.3.4.1.2 Market size and forecast, by Application
      • 6.3.4.2 France
      • 6.3.4.2.1 Market size and forecast, by Target Microorganism
      • 6.3.4.2.2 Market size and forecast, by Application
      • 6.3.4.3 UK
      • 6.3.4.3.1 Market size and forecast, by Target Microorganism
      • 6.3.4.3.2 Market size and forecast, by Application
      • 6.3.4.4 Italy
      • 6.3.4.4.1 Market size and forecast, by Target Microorganism
      • 6.3.4.4.2 Market size and forecast, by Application
      • 6.3.4.5 Spain
      • 6.3.4.5.1 Market size and forecast, by Target Microorganism
      • 6.3.4.5.2 Market size and forecast, by Application
      • 6.3.4.6 Russia
      • 6.3.4.6.1 Market size and forecast, by Target Microorganism
      • 6.3.4.6.2 Market size and forecast, by Application
      • 6.3.4.7 Rest of Europe
      • 6.3.4.7.1 Market size and forecast, by Target Microorganism
      • 6.3.4.7.2 Market size and forecast, by Application
  • 6.4 Asia-Pacific
    • 6.4.1 Key trends and opportunities
    • 6.4.2 Asia-Pacific Market size and forecast, by Target Microorganism
    • 6.4.3 Asia-Pacific Market size and forecast, by Application
    • 6.4.4 Asia-Pacific Market size and forecast, by country
      • 6.4.4.1 China
      • 6.4.4.1.1 Market size and forecast, by Target Microorganism
      • 6.4.4.1.2 Market size and forecast, by Application
      • 6.4.4.2 Japan
      • 6.4.4.2.1 Market size and forecast, by Target Microorganism
      • 6.4.4.2.2 Market size and forecast, by Application
      • 6.4.4.3 India
      • 6.4.4.3.1 Market size and forecast, by Target Microorganism
      • 6.4.4.3.2 Market size and forecast, by Application
      • 6.4.4.4 Australia
      • 6.4.4.4.1 Market size and forecast, by Target Microorganism
      • 6.4.4.4.2 Market size and forecast, by Application
      • 6.4.4.5 South Korea
      • 6.4.4.5.1 Market size and forecast, by Target Microorganism
      • 6.4.4.5.2 Market size and forecast, by Application
      • 6.4.4.6 Rest of Asia-Pacific
      • 6.4.4.6.1 Market size and forecast, by Target Microorganism
      • 6.4.4.6.2 Market size and forecast, by Application
  • 6.5 LAMEA
    • 6.5.1 Key trends and opportunities
    • 6.5.2 LAMEA Market size and forecast, by Target Microorganism
    • 6.5.3 LAMEA Market size and forecast, by Application
    • 6.5.4 LAMEA Market size and forecast, by country
      • 6.5.4.1 Brazil
      • 6.5.4.1.1 Market size and forecast, by Target Microorganism
      • 6.5.4.1.2 Market size and forecast, by Application
      • 6.5.4.2 Argentina
      • 6.5.4.2.1 Market size and forecast, by Target Microorganism
      • 6.5.4.2.2 Market size and forecast, by Application
      • 6.5.4.3 UAE
      • 6.5.4.3.1 Market size and forecast, by Target Microorganism
      • 6.5.4.3.2 Market size and forecast, by Application
      • 6.5.4.4 Turkey
      • 6.5.4.4.1 Market size and forecast, by Target Microorganism
      • 6.5.4.4.2 Market size and forecast, by Application
      • 6.5.4.5 South Africa
      • 6.5.4.5.1 Market size and forecast, by Target Microorganism
      • 6.5.4.5.2 Market size and forecast, by Application
      • 6.5.4.6 Rest of LAMEA
      • 6.5.4.6.1 Market size and forecast, by Target Microorganism
      • 6.5.4.6.2 Market size and forecast, by Application

CHAPTER 7: COMPANY LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Key developments

CHAPTER 8: COMPANY PROFILES

  • 8.1 Aristomenis D. Phikas and Co SA.
    • 8.1.1 Company overview
    • 8.1.2 Company snapshot
    • 8.1.3 Operating business segments
    • 8.1.4 Product portfolio
    • 8.1.5 Business performance
    • 8.1.6 Key strategic moves and developments
  • 8.2 Biochem S.R.L
    • 8.2.1 Company overview
    • 8.2.2 Company snapshot
    • 8.2.3 Operating business segments
    • 8.2.4 Product portfolio
    • 8.2.5 Business performance
    • 8.2.6 Key strategic moves and developments
  • 8.3 CHR. HANSEN HOLDING A/S
    • 8.3.1 Company overview
    • 8.3.2 Company snapshot
    • 8.3.3 Operating business segments
    • 8.3.4 Product portfolio
    • 8.3.5 Business performance
    • 8.3.6 Key strategic moves and developments
  • 8.4 Dalton Biotecnologie S.r.l
    • 8.4.1 Company overview
    • 8.4.2 Company snapshot
    • 8.4.3 Operating business segments
    • 8.4.4 Product portfolio
    • 8.4.5 Business performance
    • 8.4.6 Key strategic moves and developments
  • 8.5 DSM
    • 8.5.1 Company overview
    • 8.5.2 Company snapshot
    • 8.5.3 Operating business segments
    • 8.5.4 Product portfolio
    • 8.5.5 Business performance
    • 8.5.6 Key strategic moves and developments
  • 8.6 M Food Group GMBH
    • 8.6.1 Company overview
    • 8.6.2 Company snapshot
    • 8.6.3 Operating business segments
    • 8.6.4 Product portfolio
    • 8.6.5 Business performance
    • 8.6.6 Key strategic moves and developments
  • 8.7 Proxis Developpement
    • 8.7.1 Company overview
    • 8.7.2 Company snapshot
    • 8.7.3 Operating business segments
    • 8.7.4 Product portfolio
    • 8.7.5 Business performance
    • 8.7.6 Key strategic moves and developments
  • 8.8 Puratos Group NV
    • 8.8.1 Company overview
    • 8.8.2 Company snapshot
    • 8.8.3 Operating business segments
    • 8.8.4 Product portfolio
    • 8.8.5 Business performance
    • 8.8.6 Key strategic moves and developments
  • 8.9 Sacco S.R.L
    • 8.9.1 Company overview
    • 8.9.2 Company snapshot
    • 8.9.3 Operating business segments
    • 8.9.4 Product portfolio
    • 8.9.5 Business performance
    • 8.9.6 Key strategic moves and developments
  • 8.10 Soyuzsnab Group of Companies
    • 8.10.1 Company overview
    • 8.10.2 Company snapshot
    • 8.10.3 Operating business segments
    • 8.10.4 Product portfolio
    • 8.10.5 Business performance
    • 8.10.6 Key strategic moves and developments
Product Code: A16877

LIST OF TABLES

  • TABLE 1. GLOBAL BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY TARGET MICROORGANISM, 2021-2031 ($MILLION)
  • TABLE 2. BACTERIOCINS AND PROTECTIVE CULTURES MARKET, FOR YEASTS AND MOLDS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. BACTERIOCINS AND PROTECTIVE CULTURES MARKET FOR YEASTS AND MOLDS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. BACTERIOCINS AND PROTECTIVE CULTURES MARKET, FOR BACTERIA, BY REGION, 2021-2031 ($MILLION)
  • TABLE 5. BACTERIOCINS AND PROTECTIVE CULTURES MARKET FOR BACTERIA, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 6. GLOBAL BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 7. BACTERIOCINS AND PROTECTIVE CULTURES MARKET, FOR DAIRY AND DAIRY PRODUCTS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 8. BACTERIOCINS AND PROTECTIVE CULTURES MARKET FOR DAIRY AND DAIRY PRODUCTS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 9. BACTERIOCINS AND PROTECTIVE CULTURES MARKET, FOR MEAT AND POULTRY PRODUCTS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 10. BACTERIOCINS AND PROTECTIVE CULTURES MARKET FOR MEAT AND POULTRY PRODUCTS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 11. BACTERIOCINS AND PROTECTIVE CULTURES MARKET, FOR SEAFOOD, BY REGION, 2021-2031 ($MILLION)
  • TABLE 12. BACTERIOCINS AND PROTECTIVE CULTURES MARKET FOR SEAFOOD, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 13. BACTERIOCINS AND PROTECTIVE CULTURES MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 14. BACTERIOCINS AND PROTECTIVE CULTURES MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 15. BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 16. NORTH AMERICA BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY TARGET MICROORGANISM, 2021-2031 ($MILLION)
  • TABLE 17. NORTH AMERICA BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 18. NORTH AMERICA BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 19. U.S. BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY TARGET MICROORGANISM, 2021-2031 ($MILLION)
  • TABLE 20. U.S. BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 21. CANADA BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY TARGET MICROORGANISM, 2021-2031 ($MILLION)
  • TABLE 22. CANADA BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 23. MEXICO BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY TARGET MICROORGANISM, 2021-2031 ($MILLION)
  • TABLE 24. MEXICO BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 25. EUROPE BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY TARGET MICROORGANISM, 2021-2031 ($MILLION)
  • TABLE 26. EUROPE BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 27. EUROPE BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 28. GERMANY BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY TARGET MICROORGANISM, 2021-2031 ($MILLION)
  • TABLE 29. GERMANY BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 30. FRANCE BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY TARGET MICROORGANISM, 2021-2031 ($MILLION)
  • TABLE 31. FRANCE BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 32. UK BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY TARGET MICROORGANISM, 2021-2031 ($MILLION)
  • TABLE 33. UK BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 34. ITALY BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY TARGET MICROORGANISM, 2021-2031 ($MILLION)
  • TABLE 35. ITALY BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 36. SPAIN BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY TARGET MICROORGANISM, 2021-2031 ($MILLION)
  • TABLE 37. SPAIN BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 38. RUSSIA BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY TARGET MICROORGANISM, 2021-2031 ($MILLION)
  • TABLE 39. RUSSIA BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 40. REST OF EUROPE BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY TARGET MICROORGANISM, 2021-2031 ($MILLION)
  • TABLE 41. REST OF EUROPE BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 42. ASIA-PACIFIC BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY TARGET MICROORGANISM, 2021-2031 ($MILLION)
  • TABLE 43. ASIA-PACIFIC BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 44. ASIA-PACIFIC BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 45. CHINA BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY TARGET MICROORGANISM, 2021-2031 ($MILLION)
  • TABLE 46. CHINA BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 47. JAPAN BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY TARGET MICROORGANISM, 2021-2031 ($MILLION)
  • TABLE 48. JAPAN BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 49. INDIA BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY TARGET MICROORGANISM, 2021-2031 ($MILLION)
  • TABLE 50. INDIA BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 51. AUSTRALIA BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY TARGET MICROORGANISM, 2021-2031 ($MILLION)
  • TABLE 52. AUSTRALIA BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 53. SOUTH KOREA BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY TARGET MICROORGANISM, 2021-2031 ($MILLION)
  • TABLE 54. SOUTH KOREA BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 55. REST OF ASIA-PACIFIC BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY TARGET MICROORGANISM, 2021-2031 ($MILLION)
  • TABLE 56. REST OF ASIA-PACIFIC BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 57. LAMEA BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY TARGET MICROORGANISM, 2021-2031 ($MILLION)
  • TABLE 58. LAMEA BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 59. LAMEA BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 60. BRAZIL BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY TARGET MICROORGANISM, 2021-2031 ($MILLION)
  • TABLE 61. BRAZIL BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 62. ARGENTINA BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY TARGET MICROORGANISM, 2021-2031 ($MILLION)
  • TABLE 63. ARGENTINA BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 64. UAE BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY TARGET MICROORGANISM, 2021-2031 ($MILLION)
  • TABLE 65. UAE BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 66. TURKEY BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY TARGET MICROORGANISM, 2021-2031 ($MILLION)
  • TABLE 67. TURKEY BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 68. SOUTH AFRICA BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY TARGET MICROORGANISM, 2021-2031 ($MILLION)
  • TABLE 69. SOUTH AFRICA BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 70. REST OF LAMEA BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY TARGET MICROORGANISM, 2021-2031 ($MILLION)
  • TABLE 71. REST OF LAMEA BACTERIOCINS AND PROTECTIVE CULTURES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 72.ARISTOMENIS D. PHIKAS AND CO SA.: COMPANY SNAPSHOT
  • TABLE 73.ARISTOMENIS D. PHIKAS AND CO SA.: OPERATING SEGMENTS
  • TABLE 74.ARISTOMENIS D. PHIKAS AND CO SA.: PRODUCT PORTFOLIO
  • TABLE 75.ARISTOMENIS D. PHIKAS AND CO SA.: NET SALES,
  • TABLE 76.ARISTOMENIS D. PHIKAS AND CO SA.: KEY STRATERGIES
  • TABLE 77.BIOCHEM S.R.L: COMPANY SNAPSHOT
  • TABLE 78.BIOCHEM S.R.L: OPERATING SEGMENTS
  • TABLE 79.BIOCHEM S.R.L: PRODUCT PORTFOLIO
  • TABLE 80.BIOCHEM S.R.L: NET SALES,
  • TABLE 81.BIOCHEM S.R.L: KEY STRATERGIES
  • TABLE 82.CHR. HANSEN HOLDING A/S: COMPANY SNAPSHOT
  • TABLE 83.CHR. HANSEN HOLDING A/S: OPERATING SEGMENTS
  • TABLE 84.CHR. HANSEN HOLDING A/S: PRODUCT PORTFOLIO
  • TABLE 85.CHR. HANSEN HOLDING A/S: NET SALES,
  • TABLE 86.CHR. HANSEN HOLDING A/S: KEY STRATERGIES
  • TABLE 87.DALTON BIOTECNOLOGIE S.R.L: COMPANY SNAPSHOT
  • TABLE 88.DALTON BIOTECNOLOGIE S.R.L: OPERATING SEGMENTS
  • TABLE 89.DALTON BIOTECNOLOGIE S.R.L: PRODUCT PORTFOLIO
  • TABLE 90.DALTON BIOTECNOLOGIE S.R.L: NET SALES,
  • TABLE 91.DALTON BIOTECNOLOGIE S.R.L: KEY STRATERGIES
  • TABLE 92.DSM: COMPANY SNAPSHOT
  • TABLE 93.DSM: OPERATING SEGMENTS
  • TABLE 94.DSM: PRODUCT PORTFOLIO
  • TABLE 95.DSM: NET SALES,
  • TABLE 96.DSM: KEY STRATERGIES
  • TABLE 97.M FOOD GROUP GMBH: COMPANY SNAPSHOT
  • TABLE 98.M FOOD GROUP GMBH: OPERATING SEGMENTS
  • TABLE 99.M FOOD GROUP GMBH: PRODUCT PORTFOLIO
  • TABLE 100.M FOOD GROUP GMBH: NET SALES,
  • TABLE 101.M FOOD GROUP GMBH: KEY STRATERGIES
  • TABLE 102.PROXIS DEVELOPPEMENT: COMPANY SNAPSHOT
  • TABLE 103.PROXIS DEVELOPPEMENT: OPERATING SEGMENTS
  • TABLE 104.PROXIS DEVELOPPEMENT: PRODUCT PORTFOLIO
  • TABLE 105.PROXIS DEVELOPPEMENT: NET SALES,
  • TABLE 106.PROXIS DEVELOPPEMENT: KEY STRATERGIES
  • TABLE 107.PURATOS GROUP NV: COMPANY SNAPSHOT
  • TABLE 108.PURATOS GROUP NV: OPERATING SEGMENTS
  • TABLE 109.PURATOS GROUP NV: PRODUCT PORTFOLIO
  • TABLE 110.PURATOS GROUP NV: NET SALES,
  • TABLE 111.PURATOS GROUP NV: KEY STRATERGIES
  • TABLE 112.SACCO S.R.L: COMPANY SNAPSHOT
  • TABLE 113.SACCO S.R.L: OPERATING SEGMENTS
  • TABLE 114.SACCO S.R.L: PRODUCT PORTFOLIO
  • TABLE 115.SACCO S.R.L: NET SALES,
  • TABLE 116.SACCO S.R.L: KEY STRATERGIES
  • TABLE 117.SOYUZSNAB GROUP OF COMPANIES: COMPANY SNAPSHOT
  • TABLE 118.SOYUZSNAB GROUP OF COMPANIES: OPERATING SEGMENTS
  • TABLE 119.SOYUZSNAB GROUP OF COMPANIES: PRODUCT PORTFOLIO
  • TABLE 120.SOYUZSNAB GROUP OF COMPANIES: NET SALES,
  • TABLE 121.SOYUZSNAB GROUP OF COMPANIES: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.BACTERIOCINS AND PROTECTIVE CULTURES MARKET SEGMENTATION
  • FIGURE 2.BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031
  • FIGURE 3.BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.BACTERIOCINS AND PROTECTIVE CULTURES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.BACTERIOCINS AND PROTECTIVE CULTURES MARKET,BY TARGET MICROORGANISM,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF YEASTS AND MOLDS BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF BACTERIA BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031(%)
  • FIGURE 15.BACTERIOCINS AND PROTECTIVE CULTURES MARKET,BY APPLICATION,2021(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF DAIRY AND DAIRY PRODUCTS BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF MEAT AND POULTRY PRODUCTS BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF SEAFOOD BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF OTHERS BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031(%)
  • FIGURE 20.BACTERIOCINS AND PROTECTIVE CULTURES MARKET BY REGION,2021
  • FIGURE 21.U.S. BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031($MILLION)
  • FIGURE 22.CANADA BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031($MILLION)
  • FIGURE 23.MEXICO BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031($MILLION)
  • FIGURE 24.GERMANY BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031($MILLION)
  • FIGURE 25.FRANCE BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031($MILLION)
  • FIGURE 26.UK BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031($MILLION)
  • FIGURE 27.ITALY BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031($MILLION)
  • FIGURE 28.SPAIN BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031($MILLION)
  • FIGURE 29.RUSSIA BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031($MILLION)
  • FIGURE 30.REST OF EUROPE BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031($MILLION)
  • FIGURE 31.CHINA BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031($MILLION)
  • FIGURE 32.JAPAN BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031($MILLION)
  • FIGURE 33.INDIA BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031($MILLION)
  • FIGURE 34.AUSTRALIA BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031($MILLION)
  • FIGURE 35.SOUTH KOREA BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031($MILLION)
  • FIGURE 36.REST OF ASIA-PACIFIC BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031($MILLION)
  • FIGURE 37.BRAZIL BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031($MILLION)
  • FIGURE 38.ARGENTINA BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031($MILLION)
  • FIGURE 39.UAE BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031($MILLION)
  • FIGURE 40.TURKEY BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031($MILLION)
  • FIGURE 41.SOUTH AFRICA BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031($MILLION)
  • FIGURE 42.REST OF LAMEA BACTERIOCINS AND PROTECTIVE CULTURES MARKET,2021-2031($MILLION)
  • FIGURE 43. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 46.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 47.COMPETITIVE DASHBOARD
  • FIGURE 48.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 49.ARISTOMENIS D. PHIKAS AND CO SA..: NET SALES ,($MILLION)
  • FIGURE 50.BIOCHEM S.R.L.: NET SALES ,($MILLION)
  • FIGURE 51.CHR. HANSEN HOLDING A/S.: NET SALES ,($MILLION)
  • FIGURE 52.DALTON BIOTECNOLOGIE S.R.L.: NET SALES ,($MILLION)
  • FIGURE 53.DSM.: NET SALES ,($MILLION)
  • FIGURE 54.M FOOD GROUP GMBH.: NET SALES ,($MILLION)
  • FIGURE 55.PROXIS DEVELOPPEMENT.: NET SALES ,($MILLION)
  • FIGURE 56.PURATOS GROUP NV.: NET SALES ,($MILLION)
  • FIGURE 57.SACCO S.R.L.: NET SALES ,($MILLION)
  • FIGURE 58.SOYUZSNAB GROUP OF COMPANIES.: NET SALES ,($MILLION)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!